Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Simultaneous targeting of 5-LOX-COX and EGFR blocks progression of pancreatic ductal adenocarcinoma.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Simultaneous targeting of 5-LOX-COX and EGFR blocks progression of pancreatic ductal adenocarcinoma.
Simultaneous targeting of 5-LOX-COX and EGFR blocks progression of pancreatic ductal adenocarcinoma. Oncotarget. 2015 Oct 20; 6(32):33290-305.
View in:
PubMed
subject areas
Animals
Antineoplastic Agents
Arachidonate 5-Lipoxygenase
Carcinoma, Pancreatic Ductal
Cyclooxygenase 2
Cyclooxygenase 2 Inhibitors
Drug Synergism
ErbB Receptors
Female
Lipoxygenase Inhibitors
Male
Mice
Mice, Inbred C57BL
Mice, Transgenic
Pancreatic Neoplasms
Pyrroles
Quinazolines
Signal Transduction
authors with profiles
Venkateshwar Madka